510(k) Report

FDA applicant

Helena Laboratories

Beaumont, TX282 decisions1978–20229 recalls

FDA records 282 decisions for Helena Laboratories (Beaumont, TX) from 1978 to 2022: 282 510(k) clearances. Most are in product codes LCP (Assay, Glycosylated Hemoglobin) and GGP (Test, Qualitative And Quantitative Factor…). Its devices cite 2 predicates, 0 of them its own earlier devices. 9 recalls are linked to its devices.

FDA’s records also spell it “Helena Laboratories, Corp.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, hematology panel, where it files most

How often FDA has decided Helena Laboratories’s devices, and how often a recall has named them.

FDA decisions per year

2in 2022

2007: 12010: 12013: 12022: 2
2007high 2 (2022) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

1in 2020

2016: 22017: 12018: 52020: 1
2007high 5 (2018) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Helena Laboratories by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Helena Laboratories’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Helena”

FDA records each applicant name separately; these may or may not be the same firm.